Cross-fostering in combination with ivermectin therapy: A method to eradicate murine fur mites

Contemporary Topics in Laboratory Animal Science

Volumn 44, Issue 4, 2005, Pages 12-16

  Huerkamp, Michael J ^a   Zitzow, Lois A ^a   Webb, Sonji ^a   Pullium, Jennifer K ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARICIDE; IVERMECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CESAREAN SECTION; CONTROL SYSTEM; CONTROLLED STUDY; CROSS FOSTERING; ERADICATION THERAPY; HYSTERECTOMY; INFESTATION; MITE; MOUSE; NONHUMAN; OUTBREEDING; PHENOTYPE; RELIABILITY; SICKLE CELL ANEMIA;

ANIMAL HUSBANDRY; ANIMALS; FEMALE; IVERMECTIN; LACTATION; MICE; MICE, MUTANT STRAINS; MITE INFESTATIONS; RODENT DISEASES;

ACARI; MURINAE; MYOCOPTES;

EID: 22844451302     PISSN: 10600558     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bittner, J. J. 1936. Some possible effects of nursing on the mammary gland tumor incidence in mice. Science 84:162.
2. Burdett, E. C., R. A. Heckmann, and R. Ochoa. 1997. Evaluation of five treatment regimens and five diagnostic methods for murine mites (Myocoptes musculinus and Myobia musculi). Contemp. Top. Lab. Anim. Sci. 36(2):73-76.
3. Campbell, W. C., M. H. Fisher, E. O. Stapley, G. Albers-Schonberg, and T. A. Jacob. 1983. Ivermectin: a potent new antiparasitic agent. Science 221:823-828.
4. Conole, J., M. J. Wilkinson, and Q. A. McKellar. 2003. Some observations on the pharmacological properties of ivermectin during treatment of a mite infestation in mice. Contemp. Top. Lab. Anim. Sci. 42(4):42-45.
5. Forbes, D. 1994. FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit breeding colonies. Lab. Anim. 28:279-280.
6. Friedman, S. and S. H. Weisbroth. 1975. The parasitic ecology of the rodent mite Myobia musculi. II. Genetic factors. Lab. Anim. Sci. 25:440-445.
7. Hobbs, B. A., J. Kavanaugh, and W. B. Sapanski. 1989. Hysterectomy-derivation to eliminate specific murine pathogens. Lab Anim. (N.Y.) 18:35-40.
8. Hogan, B. B., F. Constantini, and E. Lacy. 1994. Section A: summary of mouse development, p. 26. In B. B. Hogan, R. Beddington, F. Constantini, and E. Lacy (ed.), Manipulating the mouse embryo: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
9. Jacoby, R. O., J. G. Fox, and M. Davisson. 2002. Biology and diseases of mice, p. 102-105. In J. G. Fox, L. C. Anderson, F. M. Loew, and F. W. Quimby (ed.), Laboratory animal medicine, 2nd ed. Academic Press, Inc., Orlando, Fla.
10. Jacoby, R. O. and J. R. Lindsey. 1998. Risks of infection among laboratory rats and mice at major biomedical research institutions. ILAR J. 39:266-271.
11. Lankas, G. R., M. E. Cartwright, and D. Umbenhauer. 1997. P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity. Toxicol Appl Pharmacol 143:357-365.
12. Lipman, N. S., C. E. Newcomer, and J. G. Fox. 1987. Rederivation of MHV and MEV antibody positive mice by cross-fostering and use of the microisolator caging system. Lab. Anim. Sci. 37:195-199.
13. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academies Press, Washington, D.C.
14. Owen, D. G. 1992. Ectoparasites, p. 13-38. In Parasites of laboratory animals. Laboratory animals handbooks no. 12. Laboratory Animals Ltd., London.
15. Paszty, C., C. M. Brion, E. Manci, H. E. Witkowska, M. E. Stevens, N. Mohandas, and E. M. Rubin. 1997. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science 278:876-878.
16. Pence, B. C., D. S. Demick, B. C. Richard, and F. Buddingh. 1991. The efficacy and safety of chlorpyrifos (Dursban) for control of Myobia musculi infestation in mice. Lab. Anim. Sci. 41:139-142.
17. Pallium, J. K., W. J. Brooks, A. O. Langley, and M. J. Huerkamp. 2005. A single dose of topical moxidectin as an effective treatment for murine acariasis due to myocoptes musculinus. Contemp. Top. Lab. Anim. Sci. 44(1):26-28.
18. Rehg, J. E. and L. A. Toth. 1998. Rodent quarantine programs: purpose, principles, and practice. Lab. Anim. Sci. 48:438-447.
19. Schinkel, A. H., J. J. Smit, O. van Tellingen, J. H. Beijnen, E. Wagenaar, L. van Deemter, C. A. Mol, M. A. van der Valk, E. C. Robanus-Maandag, and H. P. te Riele. 1994. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502.
20. Singletary, K. B., C. A. Kloster, and D. G. Baker. 2003. Optimal age at fostering for derivation of Helicobacter hepaticus-free mice. Comp. Med. 53:259-264.
21. Skopets, B., R. P. Wilson, J. W. Griffith, and C. M. Lang. 1996. Ivermectin toxicity in young mice. Lab. Anim. Sci. 46:111-112.
22. Small, J. D. 1984. Rodent and lagomorph health surveillance-quality assurance, p. 709-723. In J. G. Fox, B. J. Cohen, and F. M. Loew (ed.), Laboratory animal medicine. Academic Press Inc., Orlando, Fla.
23. Toth, L. A., C. Oberbeck, C. M. Straign, S. Frazier, and J. E. Rehg. 2000. Toxicity evaluation of prophylactic treatments for mites and pinworms in mice. Contemp. Top. Lab. Anim. Sci. 39(2):18-21.
24. Weisbroth, S. H. 1982. Arthropods, p. 385-402. In H. L. Foster, J. D. Small, and J. G. Fox (ed.), The mouse in biomedical research. Volume II: diseases. Academic Press, Inc., Orlando, Fla.
25. Weisbroth, S. H., S. Friedman, M. Powell, and S. Scher. 1974. The parasitic ecology of the rodent mite Myobia musculi. I. Grooming factors. Lab. Anim. Sci. 24:510-516.
26. Weisbroth, S. H., R. Peters, L. K. Riley, and W. Shek. 1998. Microbiological assessment of laboratory rats and mice. ILAR J. 39:274.
27. Wing, S. R., C. H. Courtney, and M. D. Young. 1985. Effect of ivermectin on murine mites. J Am Vet Med Assoc 187:1191-1192.